# Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract

> **NCT00825721** · PHASE2 · UNKNOWN · sponsor: **Chakshu Research, Inc.** · enrollment: 81 (actual)

## Conditions studied

- Nuclear Cataract

## Interventions

- **DRUG:** LiquiTears
- **DRUG:** C-KAD Ophthalmic Solution
- **DRUG:** C-KAD Ophthalmic Solution
- **DRUG:** C-KAD Ophthalmic Solution

## Key facts

- **NCT ID:** NCT00825721
- **Lead sponsor:** Chakshu Research, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-11
- **Primary completion:** 2009-08
- **Final completion:** 2009-09
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2009-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00825721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00825721, "Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear Cataract". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00825721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*